Chemoinformaics analysis of TRITRIACONTAN-3-ONE
Molecular Weight | 478.89 | nRot | 30 |
Heavy Atom Molecular Weight | 412.362 | nRig | 49 |
Exact Molecular Weight | 478.511 | nRing | 0 |
Solubility: LogS | -4.556 | nHRing | 0 |
Solubility: LogP | 4.476 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 100 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 66 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 33 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 99.9203 |
nHD | 0 | BPOL | 67.0797 |
QED | 0.144 |
Synth | 7.21 |
Natural Product Likeliness | 1.587 |
NR-PPAR-gamma | 0.104 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.334 |
Pgp-sub | 0.971 |
HIA | 0.958 |
CACO-2 | -5.29 |
MDCK | 0.0000155 |
BBB | 0.232 |
PPB | 0.82699 |
VDSS | 1.558 |
FU | 0.122237 |
CYP1A2-inh | 0.003 |
CYP1A2-sub | 0.983 |
CYP2c19-inh | 0.054 |
CYP2c19-sub | 0.937 |
CYP2c9-inh | 0.113 |
CYP2c9-sub | 0.358 |
CYP2d6-inh | 0.946 |
CYP2d6-sub | 0.862 |
CYP3a4-inh | 0.928 |
CYP3a4-sub | 0.937 |
CL | 2.635 |
T12 | 0.001 |
hERG | 0.798 |
Ames | 0.062 |
ROA | 0.996 |
SkinSen | 0.008 |
Carcinogencity | 0.779 |
EI | 0.005 |
Respiratory | 0.965 |
NR-Aromatase | 0.213 |
Antiviral | No |
Prediction | 0.608087 |